ClinicalTrials.Veeva

Menu

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Wyeth logo

Wyeth

Status

Completed

Conditions

Acute Myeloid Leukemia

Treatments

Drug: Mylotarg

Study type

Observational

Funder types

Industry

Identifiers

NCT00161668
0903X-100847

Details and patient eligibility

About

This study is designed to assess the safety of Mylotarg therapy in routine practice.

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Treated by Mylotarg
  • Provide ICF

Trial contacts and locations

59

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems